Dr. Shaw Shahriar Eslamian, MD

Dr. Eslamian practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Eslamian's NPI, 1740467224, was assigned on January 27, 2008. Dr. Eslamian graduated from American University of the Caribbean School of Medicine in 2005. Dr. Eslamian's California license number on file is A101252.

Dr. Eslamian's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Eslamian's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Eslamian to 2 more skilled nursing facilities, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eslamian practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Eslamian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Eslamian has a license on file in California.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, anemia, cardiac arrhythmia, cellulitis, chronic anemia and chronic diabetes among the conditions Dr. Eslamian treats.

CMS data shows 1,338 Medicare services from Dr. Eslamian across 8 procedure codes in 2024, for 275 Medicare patients. Medicare paid $128,069 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 275 Medicare patients who saw Dr. Eslamian in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eslamian's median patient age at 72, with 49% women.

In 2024, Dr. Eslamian wrote 1,712 Medicare Part D claims for 337 patients. 81% of them were for generic drugs. CMS names the drug for 1,257 of them, across 50 drugs with 11 or more claims each, at $53,339 in total drug cost. In 2023, CMS named 1,696 claims across 57 drugs.

Dr. Eslamian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 55 general payments to Dr. Eslamian from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $352.

Dr. Eslamian graduated from American University of the Caribbean School of Medicine in 2005.

Dr. Eslamian is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.